CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Clinical Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B-cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma (Multicenter, Open-label).

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01718691
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:14.195363+00:00
Published At: 2016-04-27T00:00:00+00:00
Record Updated At: 2016-04-27
Results Posted At: 2016-04-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Low-grade B Cell Non-Hodgkin\u0027s Lymphoma", "Mantle Cell Lymphoma Where Hematopoietic Stem Cell Transplantation is Not Indicated"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-04-27"
protocolSection.identificationModule.nctId: "NCT01718691"
protocolSection.identificationModule.officialTitle: "Phase II Clinical Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B-cell Non-Hodgkin\u0027s Lymphoma and Mantle Cell Lymphoma (Multicenter, Open-label)."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-04-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.